Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.
about
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expressionEnhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidaseEnvironmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallardsOseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a reviewLarge-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance.Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling study.Assessing the ecotoxicologic hazards of a pandemic influenza medical responseAdamantane- and oseltamivir-resistant seasonal A (H1N1) and pandemic A (H1N1) 2009 influenza viruses in Guangdong, China, during 2008 and 2009A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase.The global spread of drug-resistant influenza.Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistanceA two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivirPermissive secondary mutations enable the evolution of influenza oseltamivir resistance.Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, JapanStudy of oseltamivir and zanamivir resistance-related mutations in influenza viruses isolated from wild mallards in SwedenInfluenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008.Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza virusesGenital herpes in Canada: Deciphering the hidden epidemicModeling the global transmission of antiviral-resistant influenza viruses.Oseltamivir-resistant influenza viruses get by with a little help from permissive mutations.Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.Antiviral drugs for treatment of patients infected with pandemic (H1N1) 2009 virus.XIth International Symposium on Respiratory Viral Infections.Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC E): the ALIC E protocol
P2860
Q21135459-30F32DEC-9038-42DA-BDF6-6A4CEB79C299Q28387364-AB108D24-7B68-47A7-BAC7-9550E3E67EEAQ28477046-CB8B1448-D725-47DC-A7F1-81755DC9F1B9Q30224096-A2DDAD35-E5D6-4189-8596-495982F95C4FQ30379476-3B010054-CE4E-48FD-A8A6-E12AE2E20E2CQ30386485-67C2CA62-83A3-4A19-9A3A-A36234A0068EQ30392964-D7428E73-464D-4FEC-8D51-8B9F9ECCDCC1Q30394187-33873708-17BA-4F90-9AFD-7E3D6541DD4FQ30395977-7127A3DB-1740-4AA3-9F7A-0B538D59FF70Q30400339-8CB6A8A9-37B9-460D-B4C4-AC9ED7C0684CQ30402874-21631339-4FD9-44C2-99A3-AE57FE343834Q30405350-DD44B42A-EE3E-4F1F-8A46-1F26C26CD5F7Q30406360-45ABFA4D-4893-4353-B0C9-7E80CE26B2DDQ30413246-03FAD036-8DF2-407B-B45C-7976A6E5DEBCQ33761668-B52140E0-065D-4135-8EDF-F1738BE22188Q34118992-F7852E40-F7DB-4495-9816-5EBD789C37CCQ34908186-831B1F42-80BE-4DE7-A63E-8C54889E2492Q35099847-79CE75B1-AF4A-4DAF-BBA6-E8A42A5E4720Q35645982-BA382EEB-2B40-49BA-B766-B0AFE9594D67Q35666012-578E3845-1649-493C-A604-1FDADCEA5CF9Q36029499-0D694A6B-3DBC-4AA6-BFE9-B82FDF64BBC7Q37105434-56AB4164-445C-4691-9C94-F5A0CAF9CF92Q39759213-A81E459D-CE02-426D-A81F-D590F82D4BC5Q39900826-1AFC22D1-01D6-4D26-AD40-B640702B121DQ42832102-7746F25B-DF07-47AA-AC91-CBE299F2CB6CQ49745741-1CECC9EF-0B9D-434E-BB88-C3F3666F4B40Q57094242-157DF28E-26FA-4B4D-B5C4-2F4D9C223655
P2860
Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Use of oseltamivir in 12 Europ ...... ant influenza A(H1N1) viruses.
@ast
Use of oseltamivir in 12 Europ ...... ant influenza A(H1N1) viruses.
@en
type
label
Use of oseltamivir in 12 Europ ...... ant influenza A(H1N1) viruses.
@ast
Use of oseltamivir in 12 Europ ...... ant influenza A(H1N1) viruses.
@en
prefLabel
Use of oseltamivir in 12 Europ ...... ant influenza A(H1N1) viruses.
@ast
Use of oseltamivir in 12 Europ ...... ant influenza A(H1N1) viruses.
@en
P2093
P1433
P1476
Use of oseltamivir in 12 Europ ...... tant influenza A(H1N1) viruses
@en
P2093
Dominique Monnet
P304
P356
10.2807/ESE.14.05.19112-EN
P577
2009-02-05T00:00:00Z